相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。2016 Philip S. Portoghese Medicinal Chemistry Lectureship: Designing Bivalent or Bitopic Molecules for G-Protein Coupled Receptors. The Whole Is Greater Than the Sum of Its Parts
Amy Hauck Newman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Structure-Activity Relationships for a Series of (Bis(4-fluorophenyl)methyl)sulfinyl Alkyl Alicyclic Amines at the Dopamine Transporter: Functionalizing the Terminal Nitrogen Affects Affinity, Selectivity, and Metabolic Stability
Rachel D. Slack et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Dopamine and Addiction
Roy A. Wise et al.
ANNUAL REVIEW OF PSYCHOLOGY, VOL 71 (2020)
Structure-Activity Relationships of Novel Thiazole-Based Modafinil Analogues Acting at Monoamine Transporters
Predrag Kalaba et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Estimating the impact of drug use on US mortality, 1999-2016
Dana A. Glei et al.
PLOS ONE (2020)
Effects of Mirtazapine for Methamphetamine Use Disorder Among Cisgender Men and Transgender Women Who Have Sex With Men A Placebo-Controlled Randomized Clinical Trial
Phillip O. Coffin et al.
JAMA PSYCHIATRY (2020)
Structure-activity relationships for a series of (Bis(4-fluorophenyl) methyl)sulfinylethyl-aminopiperidines and -piperidine amines at the dopamine transporter: Bioisosteric replacement of the piperazine improves metabolic stability
JoLynn B. Giancola et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
(±)VK4-40, a novel dopamine D3 receptor partial agonist, attenuates cocaine reward and relapse in rodents
Chloe J. Jordan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Evaluation of Trends of Near-Real-Time Urine Drug Test Results for Methamphetamine, Cocaine, Heroin, and Fentanyl
Robert K. Twillman et al.
JAMA NETWORK OPEN (2020)
Toward Reducing HERG Affinities for Dat Inhibitors with a Combined Machine Learning and Molecular Modeling Approach
Andrew D. Fant et al.
BIOPHYSICAL JOURNAL (2019)
Translating the atypical dopamine uptake inhibitor hypothesis toward therapeutics for treatment of psychostimulant use disorders
Amy Hauck Newman et al.
NEUROPSYCHOPHARMACOLOGY (2019)
Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine
Chloe J. Jordan et al.
NEUROPHARMACOLOGY (2019)
Modulation of stress- and cocaine prime-induced reinstatement of conditioned place preference after memory extinction through dopamine D3 receptor
Rocio Guerrero-Bautista et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2019)
Investigation of Novel Primary and Secondary Pharmacophores and 3-Substitution in the Linking Chain of a Series of Highly Selective and Bitopic Dopamine D3 Receptor Antagonists and Partial Agonists
Anver Basha Shaik et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Newly Developed Dopamine D3 Receptor Antagonists, R-VK4-40 and R-VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in Rats
Chloe J. Jordan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
The treatment of cocaine use disorder
Kyle M. Kampman
SCIENCE ADVANCES (2019)
Increased Presence of Fentanyl in Cocaine-Involved Fatal Overdoses: Implications for Prevention
Michelle L. Nolan et al.
JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE (2019)
Dopamine D3R antagonist VK4-116 attenuates oxycodone self-administration and reinstatement without compromising its antinociceptive effects
Zhi-Bing You et al.
NEUROPSYCHOPHARMACOLOGY (2019)
Progress in brain cannabinoid CB2 receptor research: From genes to behavior
Chloe J. Jordan et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2019)
Pharmacogenetic role of dopamine transporter (SLC6A3) variation on response to disulfiram treatment for cocaine addiction
June P. Kampangkaew et al.
AMERICAN JOURNAL ON ADDICTIONS (2019)
Rate of Fentanyl Positivity Among Urine Drug Test Results Positive for Cocaine or Methamphetamine
Leah LaRue et al.
JAMA NETWORK OPEN (2019)
Binding modes of hERG blockers: an unsolved mystery in the drug design arena
Subha Kalyaanamoorthy et al.
EXPERT OPINION ON DRUG DISCOVERY (2018)
Quantitative Assessment of the Energetics of Dopamine Translocation by Human Dopamine Transporter
Mary Hongying Cheng et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2018)
Discovery and development of varenicline for smoking cessation
Chloe J. Jordan et al.
EXPERT OPINION ON DRUG DISCOVERY (2018)
Atypical dopamine transporter inhibitors attenuate compulsive-like methamphetamine self-administration in rats
Brendan J. Tunstall et al.
NEUROPHARMACOLOGY (2018)
Twin epidemics: The surging rise of methamphetamine use in chronic opioid users
Matthew S. Ellis et al.
DRUG AND ALCOHOL DEPENDENCE (2018)
The unique psychostimulant profile of (±)-modafinil: investigation of behavioral and neurochemical effects in mice
Maddalena Mereu et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2017)
Heterocyclic Analogues of Modafinil as Novel, Atypical Dopamine Transporter Inhibitors
Predrag Kalaba et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Highly Selective Dopamine D3 Receptor Antagonists with Arylated Diazaspiro Alkane Cores
Sean W. Reilly et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
σ Receptor Effects of N-Substituted Benztropine Analogs: Implications for Antagonism of Cocaine Self-Administration
Takato Hiranita et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Atypical dopamine transporter inhibitors R-modafinil and JHW 007 differentially affect D2 autoreceptor neurotransmission and the firing rate of midbrain dopamine neurons
Alicia J. Avelar et al.
NEUROPHARMACOLOGY (2017)
The Novel Modafinil Analog, JJC8-016, as a Potential Cocaine Abuse Pharmacotherapeutic
Hai-Ying Zhang et al.
NEUROPSYCHOPHARMACOLOGY (2017)
The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission
Danielle O. Sambo et al.
NATURE COMMUNICATIONS (2017)
A Markov State-based Quantitative Kinetic Model of Sodium Release from the Dopamine Transporter
Asghar M. Razavi et al.
SCIENTIFIC REPORTS (2017)
Recent Increases in Cocaine-Related Overdose Deaths and the Role of Opioids
Christopher McCall Jones et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2017)
Late sodium current block for drug-induced long QT syndrome: Results from a prospective clinical trial
L. Johannesen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
Highly Selective Dopamine D3 Receptor (D3R) Antagonists and Partial Agonists Based on Eticlopride and the D3R Crystal Structure: New Leads for Opioid Dependence Treatment
Vivek Kumar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Novel and High Affinity 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues as Atypical Dopamine Transporter Inhibitors
Jianjing Cao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Translation of an Adenovirus-Based Cocaine Vaccine dAd5GNE to a Clinical Trial
David F. Havlicek et al.
MOLECULAR THERAPY (2016)
Evolution of strategies to improve preclinical cardiac safety testing
Gary Gintant et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Efficacy of an adenovirus-based anti-cocaine vaccine to reduce cocaine self-administration and reacqusition using a choice procedure in rhesus macaques
Suzette M. Evans et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2016)
Evaluation of the Pipeline for Development of Medications for Cocaine Use Disorder: A Review of Translational Preclinical, Human Laboratory, and Clinical Trial Research
Paul W. Czoty et al.
PHARMACOLOGICAL REVIEWS (2016)
2-Substituted 3β-Aryltropane Cocaine Analogs Produce Atypical Effects without Inducing Inward-Facing Dopamine Transporter Conformations
Weimin C. Hong et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter
Maarten E. A. Reith et al.
DRUG AND ALCOHOL DEPENDENCE (2015)
Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis
Thomas M. Keck et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Neurotransmitter and psychostimulant recognition by the dopamine transporter
Kevin H. Wang et al.
NATURE (2015)
Differential effects of the dopamine D3 receptor antagonist PG01037 on cocaine and methamphetamine self-administration in rhesus monkeys
William S. John et al.
NEUROPHARMACOLOGY (2015)
Agonist Medications for the Treatment of Cocaine Use Disorder
S. Stevens Negus et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Preference for Distinct Functional Conformations of the Dopamine Transporter Alters the Relationship between Subjective Effects of Cocaine and Stimulation of Mesolimbic Dopamine
Stephen J. Kohut et al.
BIOLOGICAL PSYCHIATRY (2014)
Gender differences in clinical outcomes for cocaine dependence: Randomized clinical trials of behavioral therapy and disulfiram
Elise E. DeVito et al.
DRUG AND ALCOHOL DEPENDENCE (2014)
Dopamine D3 receptor alterations in cocaine-dependent humans imaged with [11C](+)PHNO
David Matuskey et al.
DRUG AND ALCOHOL DEPENDENCE (2014)
Biotransformation and bioactivation reactions of alicyclic amines in drug molecules
Jayaprakasam Bolleddula et al.
DRUG METABOLISM REVIEWS (2014)
Elucidation of Structural Elements for Selectivity across Monoamine Transporters: Novel 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues
Oluyomi M. Okunola-Bakare et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Psychiatric disorders in individuals with methamphetamine dependence: prevalence and risk factors
Taiwo Akindipe et al.
METABOLIC BRAIN DISEASE (2014)
The novel dopamine D3 receptor antagonist, SR 21502, reduces cocaine conditioned place preference in rats
P. Hachimine et al.
NEUROSCIENCE LETTERS (2014)
What is the role of the D3 receptor in addiction? A mini review of PET studies with [11C]-(+)-PHNO
Doris Payer et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2014)
Fate of Systemically Administered Cocaine in Nonhuman Primates Treated with the dAd5GNE Anticocaine Vaccine
Martin J. Hicks et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2014)
Psychostimulants and Cognition: A Continuum of Behavioral and Cognitive Activation
Suzanne Wood et al.
PHARMACOLOGICAL REVIEWS (2014)
2-Isoxazol-3-Phenyltropane Derivatives of Cocaine: Molecular and Atypical System Effects at the Dopamine Transporter
Takato Hiranita et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Pharmacological Characterization of a Dopamine Transporter Ligand That Functions as a Cocaine Antagonist
Rajeev I. Desai et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Opioid Agonist Treatments and Heroin Overdose Deaths in Baltimore, Maryland, 1995-2009
Robert P. Schwartz et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2013)
The atypical dopamine transport inhibitor, JHW 007, prevents amphetamine-induced sensitization and synaptic reorganization within the nucleus accumbens
Clara Velazquez-Sanchez et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Cariprazine (RGH-188), a D3-preferring dopamine D3/D2 receptor partial agonist antipsychotic candidate demonstrates anti-abuse potential in rats
V. Roman et al.
PSYCHOPHARMACOLOGY (2013)
The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders
Maddalena Mereu et al.
PSYCHOPHARMACOLOGY (2013)
R-Modafinil (Armodafinil): A Unique Dopamine Uptake Inhibitor and Potential Medication for Psychostimulant Abuse
Claus J. Loland et al.
BIOLOGICAL PSYCHIATRY (2012)
Mirtazapine to Reduce Methamphetamine Use A Randomized Controlled Trial
Grant N. Colfax et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Anti-Cocaine Vaccine Based on Coupling a Cocaine Analog to a Disrupted Adenovirus
George Koob et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2011)
PG01037, a novel dopamine D3 receptor antagonist, inhibits the effects of methamphetamine in rats
Amanda E. Higley et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
SARs at the Monoamine Transporters for a Novel Series of Modafinil Analogues
Jianjing Cao et al.
ACS MEDICINAL CHEMISTRY LETTERS (2011)
Decreases in Cocaine Self-Administration with Dual Inhibition of the Dopamine Transporter and σ Receptors
Takato Hiranita et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access
Laura Orio et al.
ADDICTION BIOLOGY (2010)
Regulation of the dopamine transporter Aspects relevant to psychostimulant drugs of abuse
Kyle C. Schmitt et al.
ADDICTION REVIEWS 2 (2010)
Modafinil for the treatment of cocaine dependence
Ann L. Anderson et al.
DRUG AND ALCOHOL DEPENDENCE (2009)
Mechanisms of Disulfiram-induced Cocaine Abstinence: Antabuse and Cocaine Relapse
Meriem Gaval-Cruz et al.
MOLECULAR INTERVENTIONS (2009)
The dopamine D3 receptor partial agonist CJB 090 inhibits the discriminative stimulus but not the reinforcing or priming effects of cocaine in squirrel monkeys
Cindy Achat-Mendes et al.
PSYCHOPHARMACOLOGY (2009)
Dual DAT/σ1 receptor ligands based on 3-(4-(3-(bis(4-fluorophenyl) amino) propyl) piperazin-1-yl)-1-phenylpropan-1-ol
Jianjing Cao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Interaction of cocaine-, benztropine-, and GBR12909-like compounds with wild-type and mutant human dopamine transporters: molecular features that differentially determine antagonist-binding properties
Kyle C. Schmitt et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Drug Binding to the Inactivated State Is Necessary but Not Sufficient for High-Affinity Binding to Human Ether-a-go-go-Related Gene Channels
Mark J. Perrin et al.
MOLECULAR PHARMACOLOGY (2008)
The binding sites for cocaine and dopamine in the dopamine transporter overlap
Thijs Beuming et al.
NATURE NEUROSCIENCE (2008)
Bupropion for the treatment of methamphetamine dependence
Ahmed M. Elkashef et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Smoked cocaine self-administration is decreased by modafinil
Carl L. Hart et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Effects of two novel D3-selective compounds, NGB 2904 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-9H-fluorene-2-carboxamide] and CJB 090 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)benzamide], on the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys
Jennifer L. Martelle et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
The doparnine D3 receptor antagonist NGB 2904 increases spontaneous and amphetamine-stimulated locomotion
Laurel M. Pritchard et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2007)
Effects of RGH-237 [N-{4-[4-(3-aminocarbonyl-phenyl)-piperazin-1-yl]-butyl}-4-bromo-benzamide], an orally active, selective dopamine D3 receptor partial agonist in animal models of cocaine abuse
Istvan Gyertyan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Pharmacological actions of NGB 2904, a selective dopamine D-3 receptor antagonist, in animal models of drug addiction
Zheng-Xiong Xi et al.
CNS DRUG REVIEWS (2007)
Benztropine pretreatment does not affect responses to acute cocaine administration in human volunteers
David M. Penetar et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2006)
Structure-activity relationship studies on a novel series of (S)-2β-substituted 3α-[bis(4-fluoro- or 4-chlorophenyl)methoxy]tropane analogues for in vivo investigation
Mu-Fa Zou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Medicinal chemistry of hERG optimizations: Highlights and hang-ups
Craig Jamieson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
A systematic review of modafinil: Potential clinical uses and mechanisms of action
Jacob S. Ballon et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Dopamine D3 as well as D2 receptor ligands attenuate the cue-induced cocaine-seeking in a relapse model in rats
K Gál et al.
DRUG AND ALCOHOL DEPENDENCE (2006)
N-8-substituted benztropinamine analogs as selective dopamine transporter ligands
P Grundt et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Relationship between in vivo occupancy at the dopamine transporter and behavioral effects of cocaine, GBR 12909 [1-{2-[bis-(4-fluorophenyl) methoxy]ethyl}-4-(3-phenylpropyl)piperazine], and benztropine analogs
RI Desai et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Identification of a dopamine transporter ligand that blocks the stimulant effects of cocaine
RI Desai et al.
JOURNAL OF NEUROSCIENCE (2005)
Predictive in silico modeling for hERG channelblockers
MM Aronov
DRUG DISCOVERY TODAY (2005)
A double-blind, placebo-controlled trial of modafinil for cocaine dependence
CA Dackis et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Effects of N-substituted analogs of benztropine:: Diminished cocaine-like effects in dopamine transporter ligands
JL Katz et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients - A randomized placebo-controlled trial
KM Carroll et al.
ARCHIVES OF GENERAL PSYCHIATRY (2004)
The effect of 6-substituted-4′,4-difluorobenztropines on monoamine transporters and the muscarinic M1 receptor
P Grundt et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Structure-activity relationships at monoamine transporters for a series of N-substituted 3α-(bis[4-fluorophenyl]methoxy)tropanes:: Comparative molecular field analysis, synthesis, and pharmacological evaluation
SS Kulkarni et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Structure-activity relationship comparison of (S)-2β-substituted 3α-(Bis[4-fluorophenyllmethoxy)tropanes and (R)-2β-substituted 3α-(3,4-dichlorophenyl)tropanes at the Dopamine transporter
MF Zou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Dual probes for the dopamine transporter and σ1 receptors:: novel piperazinyl alkyl-bis(4′-fluorophenyl)amine analogues as potential cocaine-abuse therapeutic agents
JJ Cao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Cocaine-seeking behavior in response to drug-associated stimuli in rats:: Involvement receptors of D3 and D2 dopamine receptors
L Cervo et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Behavioral effects of rimcazole analogues alone and in combination with cocaine
JL Katz et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Attenuation of cue-controlled cocaine-seeking by a selective D3 dopamine receptor antagonist SB-277011-A
P Di Ciano et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Probesfor the dopamine transporter: New leads toward a cocaine-abuse therapeutic - A focus on analogues of benztropine and rimcazole
AH Newman et al.
MEDICINAL RESEARCH REVIEWS (2002)
Role of the dopamine D3 receptor in reactivity to cocaine-associated cues in mice
B Le Foll et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
A dopamine D3 receptor partial agonist blocks the expression of conditioned activity
H Aujla et al.
NEUROREPORT (2002)
[3-cis-3,5-dimethyl-(1-piperazinyl)alkyl]-bis-(4′-fluorophenyl)amine analogues as novel probes for the dopamine transporter
JJ Cao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Rimcazole analogs attenuate the convulsive effects of cocaine: correlation with binding to sigma receptors rather than dopamine transporters
RR Matsumoto et al.
NEUROPHARMACOLOGY (2001)
Pharmacokinetics of the novel, high-affinity and selective dopamine D3 receptor antagonist SB-277011 in rat, dog and monkey:: in vitro/in vivo correlation and the role of aldehyde oxidase
NE Austin et al.
XENOBIOTICA (2001)
Dopamine transporter binding without cocaine-like behavioral effects: synthesis and evaluation of benztropine analogs alone and in combination with cocaine in rodents
JL Katz et al.
PSYCHOPHARMACOLOGY (2001)
Structure-activity relationships at monoamine transporters and muscarinic receptors for N-substituted-3α-(3′-chloro-, 4′-chloro-, and 4′, 4-dichloro-substituted-diphenyl)methoxytropanes
AH Newman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Highly selective chiral N-substituted 3α-[bis(4′-fluorophenyl)methoxy]tropane analogues for the dopamine transporter:: Synthesis and comparative molecular field analysis
MJ Robarge et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
分享论文
